| Literature DB >> 28523223 |
Mascha Van't Wout1,2, Sharon M Longo2, Madhavi K Reddy1,2,3, Noah S Philip1,2, Marguerite T Bowker2, Benjamin D Greenberg1,2.
Abstract
BACKGROUND: Abnormalities in fear extinction and recall are core components of posttraumatic stress disorder (PTSD). Data from animal and human studies point to a role of the ventromedial prefrontal cortex (vmPFC) in extinction learning and subsequent retention of extinction memories. Given the increasing interest in developing noninvasive brain stimulation protocols for psychopathology treatment, we piloted whether transcranial direct current stimulation (tDCS) during extinction learning, vs. during consolidation of extinction learning, might improve extinction recall in veterans with warzone-related PTSD.Entities:
Keywords: anxiety; brain stimulation; cognition; posttraumatic stress disorder; psychiatry; trauma; treatment
Mesh:
Year: 2017 PMID: 28523223 PMCID: PMC5434186 DOI: 10.1002/brb3.681
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Figure 1Current density modeling of 2 mA transcranial direct current based on 5 × 5 cm2 electrodes with the anode over the EEG coordinate AF3 and the cathode over the contralateral mastoid process using tDCS Explore neurotargeting software by SoterixMedical
Demographic and clinical characteristics of participants divided by tDCS group
| Variable | tDCS during extinction | tDCS after extinction |
|
|---|---|---|---|
|
|
| ||
| Age (years) | 53.36 (12.8) | 59.14 (11.1) | 0.21 |
| Ethnicity | 13 Caucasian, 1 African American, 0 Native American | 10 Caucasian, 3 African American, 1 Native American | 0.30 |
| Education (years) | 3 High school or less, 6 vocational/trade, 5 bachelor degree, 0 master degree | 2 High school or less, 10 vocational/trade, 1 bachelor degree, 1 master degree | 0.18 |
| Marital Status | 9 Married, 3 separated, 2 single, 0 widowed | 11 Married, 0 separated, 2 single, 1 widowed | 0.24 |
| Occupation | 5 Full‐time, 0 part‐time, 4 not employed, 5 retired | 1 Full‐time, 2 part‐time, 3 not employed, 8 retired | 0.14 |
| Combat experience | 9 Deployed once, 4 deployed ≥ 2 | 6 Deployed once, 5 deployed ≥ 2 | 0.46 |
| HOGE (5a‐5 m) | 22.69 (11.63) | 22.75 (9.54) | 0.98 |
| Comorbidity | 2 No comorbidity, 7 mood‐related disorder, 1 anxiety, 2 impulse control‐related disorder, 2 unknown | 3 No comorbidity, 5 mood‐related disorder, 1 anxiety, 2 mood and anxiety disorder, 1 impulse control‐related disorder, 2 unknown | 0.72 |
| PCL 5 | 48.60 (11.1) | 48.26 (10.3) | 0.93 |
| BAI | 21.63 (10.9) | 15.72 (7.2) | 0.11 |
| BDI‐II | 20.92 (12.1) | 24.33 (8.9) | 0.44 |
| Medication | 12 Antidepressants, 1 anxiolytics, 2 antipsychotics, 5 none | 16 Antidepressants, 5 anxiolytics, 2 antipsychotics, 2 none |
HOGE, Hoge Combat Scale – higher scores reflect higher incidence of threatening combat experiences; PCL‐5, PTSD Checklist for DSM‐V; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory.
Seventeen participants used more than one type of medication.
Figure 2Normalized skin conductance values (in μS) for CS+ and CS− trials over time for conditioning (a), extinction (b), and recall (c) separated by tDCS group